Zusammenfassung
Hypercholesterinämie (FH) ist eine autosomal vererbte Lipoproteinstoffwechselerkrankung, die durch erhöhte Gesamt- und LDL(„low density lipoprotein“)-Cholesterin-Werte im Plasma gekennzeichnet ist. Ziel dieser Erhebung mittels eines standardisierten Fragebogens war es, zu eruieren, ob und wie in österreichischen Krankenhäusern, die mit einer eigenen Kinderabteilung ausgestattet sind, Kinder und Jugendliche mit FH betreut werden. 34% der 41 Leiter/-innen gaben an, an ihren Abteilungen Kinder und Jugendliche mit FH zu behandeln. In diesen 14 Krankenhäusern werden zur Diagnostik der FH verschiedenste Kriterien herangezogen, auch die Therapiemaßnahmen werden unterschiedlich umgesetzt. Im vorliegenden Beitrag werden die unterschiedlichen Diagnoseschemata und Therapiemaßnahmen diskutiert.
Abstract
Familial hypercholesterolemia (FH) is an autosomal inherited disorder of lipoprotein characterized by markedly elevated plasma concentrations of low density lipoprotein and total cholesterol, typically well above the 95th percentile for age and gender. The aim was to investigate, using a standardized questionnaire, whether and how children and adolescents are diagnosed and treated for this condition in Austrian hospitals. Thirty-four percent of 41 departments indicated that they treat children and adolescents with FH. In these 14 hospitals, different criteria are used for diagnosis, and treatment also differs. In the following article, the different diagnosis patterns and therapeutic measures are discussed.
Literatur
American Academy of Pediatrics (1998) Committee on Nutrition. Cholesterol in childhood. Pediatrics 101: 141–147
Austin MA, Hutter CM, Zimmern RL et al. (2004) Familial hypercholesterolemia and coronary heart disease: a HuGE Association review. Am J Epidemiol 160: 421–429
Austin MA, Hutter CM, Zimmern RL et al. (2004) Genetic causes of monogenic heterozygous familial hypercholesterolemia: a HuGE prevalence review. Am J Epidemiol 160: 407–420
Brown MS, Goldstein JL (1974) Expression of the familial hypercholesterolemia gene in heterozygotes: mechanism for a dominant disorder in man. Science 185: 61–63
Civeira F (2004) International panel on management of familial hypercholesterolemia. guidelines for the diagnosis and management of heterozygous familial hypercholesterolemia. Atherosclerosis 173: 55–68
Dirisamer A, Hachemian N, Bucek RA et al. (2003) The effect of low-dose simvastatin in children with familial hypercholesterolaemia: a 1-year observation. Eur J Pediatr 162: 421–425
Goldstein JL, Brown MS (1974) Binding and degradation of low density lipoproteins by cultured human fibroblasts. Comparison of cells from a normal subject and from a patient with homozygous familial hypercholesterolemia. J Biol Chem 249: 5153–5162
Gulesserian T, Widhalm K (2002) Effect of a rapeseed oil substituting diet on serum lipids and lipoproteins in children and adolescents with familial hypercholesterolemia. J Am Coll Nutr 21: 103–108
McCrindle BW, Urbina EM, Dennison BA et al. (2007) Drug therapy of high-risk lipid abnormalities in children and adolescents. A scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee, Council of Cardiovascular Disease in the Young, with the Council on Cardiovascular Nursing. Circulation 115: 1948–1967
National Cholesterol Education Program (NCEP) (1992) Highlights of the report of the expert panel on blood cholesterol levels in children and adolescents. Pediatrics 8: 495–501
National Cholesterol Education Program NCEP (2001) Executive summary of the third report of the National Cholesterol Education Program (NCEP). Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA 285: 2486–2497
Ose L (2002) Familial hypercholesterolemia from children to adults. Cardiovasc Drugs Ther 16: 289–293
Weghuber D, Widhalm K (2008) Effect of 3-month treatment of children and adolescents with familial and polygenic hypercholesterolaemia with a soya-substituted diet. Br J Nutr 99: 281–286
Widhalm K (2007) Hyperlipoproteinämien. In: Lenze MJ, Schaub J, Schulte FJ et al. (Hrsg) Pädiatrie, Grundlagen und Praxis, 3 Aufl. Springer, Berlin Heidelberg New York, S 404–409
Widhalm K, Dirisamer A, Lindemayr A et al. (2007) Diagnosis of families with familial hypercholesterolemia (FH) and/or Apo B-100 defect by means of DNA-analysis of LDL-receptor gene mutations. J Inherit Metab Dis 30: 239–247
Interessenkonflikt
Der korrespondierende Autor weist auf folgende Beziehung/en hin: Das Projekt wird von der VOG Ag, Dir. Walter Holzner, Bäckermühlweg 44, A-4030 Linz, PF 21 gesponsert.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Dietrich, S., Miklautsch, M. & Widhalm, K. Familiäre Hypercholesterinämie bei Kindern und Jugendlichen. Monatsschr Kinderheilkd 157, 467–472 (2009). https://doi.org/10.1007/s00112-008-1877-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00112-008-1877-6